Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May:55:102760.
doi: 10.1016/j.ebiom.2020.102760. Epub 2020 May 7.

MD-2 as a possible therapeutic target for atherosclerosis

Shuang Chen  1 , Timothy R Crother  2
Affiliations
Comment

MD-2 as a possible therapeutic target for atherosclerosis

Shuang Chen et al. EBioMedicine. 2020 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare no conflict of interests.

Figures

Fig 1
Fig. 1
TLR signaling pathways and effects related to Atherosclerosis. MD2 plays a key role in TLR4 mediated pro-atherosclerotic signals.
See this image and copyright information in PMC

Comment on

References

    1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–1695. - PubMed
    1. Ridker P.M., Everett B.M., Thuren T., MacFadyen J.G., Chang W.H., Ballantyne C. Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med. 2017 - PubMed
    1. Edfeldt K., Swedenborg J., Hansson G.K., Yan Z.Q. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 2002;105(10):1158–1161. - PubMed
    1. Bjorkbacka H., Kunjathoor V.V., Moore K.J., Koehn S., Ordija C.M., Lee M.A. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med. 2004;10(4):416–421. - PubMed
    1. Michelsen K.S., Wong M.H., Shah P.K., Zhang W., Yano J., Doherty T.M. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA. 2004;101(29):10679–10684. - PMC - PubMed

Substances